One important line of investigation for the future is to perform in vivo studies of human glioma cell lines in humanized mouse models in order to fully understand the nature of the anti-tumor and pro-tumor effects of TLR4 and TLR9 agonists. This evidence concerns the gene TLR9 and central nervous system cancer.